Safeguard Scientifics, Inc.
SFES · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $6 | $5 | $7 |
| SG&A Expenses | $2 | $5 | $5 | $7 |
| Sales & Mktg Exp. | $0 | -$0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | -$0 |
| Operating Expenses | $2 | $5 | $5 | $7 |
| Operating Income | -$3 | -$6 | -$5 | -$7 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$8 | -$4 | -$9 | $34 |
| Pre-Tax Income | -$10 | -$10 | -$14 | $27 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10 | -$10 | -$14 | $27 |
| % Margin | – | – | – | – |
| EPS | -0.62 | -0.61 | -0.87 | 1.36 |
| % Growth | -1.6% | 29.9% | -164% | – |
| EPS Diluted | -0.62 | -0.61 | -0.87 | 1.36 |
| Weighted Avg Shares Out | 17 | 16 | 16 | 20 |
| Weighted Avg Shares Out Dil | 17 | 16 | 16 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$10 | -$10 | -$14 | $27 |
| % Margin | – | – | – | – |